PharmEasy is an Indian multinational e-pharmacy company that sells medicines, diagnostics, and telehealth services online. It offers a wide range of prescription and over-the-counter pharmaceutical products, comprehensive diagnostic test services, and teleconsultations to meet healthcare needs.

PharmEasy

Dr. B. Lal Lab offers diagnostic laboratory services, specializing in medical lab tests, with a focus on home sample collection.

Dr. B. Lal Lab

Cordia Pharma LTD UK operates in the healthcare industry, providing business process optimization, technology solutions, strategic sourcing, and digital transformation services. This description is self-described.

Metric
Company Name	PharmEasy	Dr. B. Lal Lab	Cordia Pharma LTD UK
Symbol
MSH ID	IN:PHARMEASY	COM:BLALLAB	COM:CORDIAPHARMA
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services
Industry	Healthcare & Health Services	Diagnostic Services	Healthcare & Health Services
Country		IN	GB
Stage
Employee Count	5.00K
Website	pharmeasy.in	blallab.com	cordiapharma.com
LinkedIn			cordia-pharma-ltd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	11.53M
Web Traffic Growth	-0.10
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PHAR

IN:PHARMEASY

PharmEasy

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue